Showing results (91-100 of 249) with videos related to

Sort By:
Pageof 25
Immunology|September 12, 2019
Cancer immune escape: MHC expression in primary tumours versus metastasesFederico Garrido, Natalia Aptsiauri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2022
The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and HopesNatalia Aptsiauri, Federico Garrido
The Journal of Investigative Dermatology|December 18, 2002
Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cellsDavid Schrama, Lars Østergaard Pedersen, Petra Keikavoussi, et al.
European Journal of Haematology|September 20, 2015
Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia veraCaroline H Riley, Marie K Brimnes, Morten Hansen, et al.
Cancer Research|March 17, 2011
Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2Rikke Bæk Sørensen, Tania Køllgaard, Rikke Sick Andersen, et al.
Cancer Research|July 18, 2015
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor ReactivityMarco Donia, Rikke Andersen, Julie W Kjeldsen, et al.
Frontiers in Immunology|December 13, 2021
Mitochondrial-Linked De Novo Pyrimidine Biosynthesis Dictates Human T-Cell Proliferation but Not Expression of Effector MoleculesMarlies J W Peeters, Pia Aehnlich, Adriano Pizzella, et al.
Plos One|April 28, 2012
Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenaseShamaila Munir, Stine Kiaer Larsen, Trine Zeeberg Iversen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53Rikke Baek Sørensen, Rikke Sick Andersen, Inge Marie Svane, et al.
European Journal of Haematology|August 2, 2014
Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-αCaroline H Riley, Morten Hansen, Marie K Brimnes, et al.
Pageof 25